RADIOLABELED PDE10A LIGANDS
    1.
    发明申请
    RADIOLABELED PDE10A LIGANDS 有权
    无线电PDE10A配置

    公开(公告)号:US20130343992A1

    公开(公告)日:2013-12-26

    申请号:US13723406

    申请日:2012-12-21

    申请人: AbbVie Inc.

    发明人: Lawrence A. Black

    摘要: Compounds of formula (I) are disclosed Compounds of formula (I) are useful in treating conditions and disorders prevented by or ameliorated by PDE10A ligands. Radiolabeled compounds of formula (I) are also useful as diagnostic tools as PDE10A positron emission tomography ligands. Also disclosed are pharmaceutical compositions comprising compound of formula (I), methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).

    摘要翻译: 公开了式(I)的化合物式(I)的化合物可用于治疗由PDE10A配体预防或改善的病症和病症。 式(I)的放射性标记化合物也可用作PDE10A正电子发射断层摄影配体的诊断工具。 还公开了包含式(I)化合物,使用这些化合物和组合物的方法以及制备式(I)范围内的化合物的方法的药物组合物。

    Radiolabeled PDE10A ligands
    5.
    发明授权
    Radiolabeled PDE10A ligands 有权
    放射性标记的PDE10A配体

    公开(公告)号:US09138494B2

    公开(公告)日:2015-09-22

    申请号:US13723406

    申请日:2012-12-21

    申请人: AbbVie Inc.

    摘要: Compounds of formula (I) are disclosed Compounds of formula (I) are useful in treating conditions and disorders prevented by or ameliorated by PDE10A ligands. Radiolabeled compounds of formula (I) are also useful as diagnostic tools as PDE10A positron emission tomography ligands. Also disclosed are pharmaceutical compositions comprising compound of formula (I), methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).

    摘要翻译: 公开了式(I)的化合物式(I)的化合物可用于治疗由PDE10A配体预防或改善的病症和病症。 式(I)的放射性标记化合物也可用作PDE10A正电子发射断层摄影配体的诊断工具。 还公开了包含式(I)化合物,使用这些化合物和组合物的方法以及制备式(I)范围内的化合物的方法的药物组合物。

    RADIOLABELED 5-HT6 LIGANDS
    6.
    发明申请
    RADIOLABELED 5-HT6 LIGANDS 审中-公开
    无标签的5-HT6配置

    公开(公告)号:US20140120036A1

    公开(公告)日:2014-05-01

    申请号:US13723422

    申请日:2012-12-21

    申请人: AbbVie Inc.

    发明人: Lawrence A. Black

    IPC分类号: A61K51/04 C07D295/112

    摘要: Compounds of formula (I) are disclosed Compounds of formula (I) are useful in treating conditions and disorders prevented by or ameliorated by 5-HT6 receptor ligands. Radiolabeled compounds of formula (I) are also useful as diagnostic tools as 5-HT6 positron emission tomography ligands. Also disclosed are pharmaceutical compositions comprising compounds of formula (I), methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).

    摘要翻译: 公开了式(I)的化合物式(I)的化合物可用于治疗5-HT 6受体配体预防或改善的病症和病症。 式(I)的放射性标记化合物也可用作5-HT6正电子发射断层摄影配体的诊断工具。 还公开了包含式(I)化合物,使用这些化合物和组合物的方法以及制备式(I)范围内的化合物的方法的药物组合物。